BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ATM, TELO1, 472, ENSG00000149311, TEL1, ATD, ATE, DKFZp781A0353, AT1, Q13315, MGC74674, ATDC, ATC, ATA AND Treatment
165 results:

  • 1. Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity.
    Shi P; Lin Z; Song Y; Li Z; Zeng M; Luo L; Cao Y; Zhu X
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):159. PubMed ID: 38530432
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Multicenter evaluation of minimal residual disease monitoring in early induction therapy for treatment of childhood acute lymphoblastic leukemia].
    Wu XJ; Liao N; Mai HR; Li XY; Wan WQ; Yang LH; Huang LB; Luo XQ; Tian C; Chen QW; Long XJ; He YY; Wang Y; Li ZG; Xu HG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(4):337-344. PubMed ID: 38527504
    [No Abstract]    [Full Text] [Related]  

  • 3. Outcome differences by sex in oncology clinical trials.
    Kammula AV; Schäffer AA; Rajagopal PS; Kurzrock R; Ruppin E
    Nat Commun; 2024 Mar; 15(1):2608. PubMed ID: 38521835
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A Bizarre Progression Of Chronic Lymphocytic Leukaemia Into Diffuse Large B-Cell lymphoma.
    Shakeel D; Qadir H; Baig MM; Ojla SM
    J Ayub Med Coll Abbottabad; 2023; 35(3):512-514. PubMed ID: 38404107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
    Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
    Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 7. Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma.
    Gong C; Wu J; Song W; Li H; Shi C; Gao Y; Shi Z; Li Z; Zhang M
    Ann Hematol; 2023 Oct; 102(10):2845-2855. PubMed ID: 37500898
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NOTCH Signaling in Mantle Cell lymphoma: Biological and Clinical Implications.
    Deshotels L; Safa FM; Saba NS
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373427
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair.
    Zhou J; Sturtevant D; Love C; Kulkarni A; Biyani N; Kathad U; Thacker E; Dave S; Bhatia K
    Oncotarget; 2023 Jun; 14():597-611. PubMed ID: 37306526
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Successful Treatment of Large B-Cell lymphoma in a Child with Compound Heterozygous Mutation in the
    Czarny J; Andrzejewska M; Zając-Spychała O; Latos-Grażyńska E; Pastorczak A; Wypyszczak K; Szczawińska-Popłonyk A; Niewiadomska-Wojnałowicz I; Wziątek A; Marciniak-Stępak P; Dopierała M; Małdyk J; Jończyk-Potoczna K; Derwich K
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674612
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. atm inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
    Shu J; Wang X; Yang X; Zhao G
    Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. [Gastric SWI/SNF complex deletion-associated undifferentiated carcinoma with rhabdoid phenotype: a clinicopathological and molecular analysis].
    Jin YP; Wang L; Wang Y; Wu DY; Zhang H; Xia QX
    Zhonghua Bing Li Xue Za Zhi; 2022 Dec; 51(12):1229-1234. PubMed ID: 36480831
    [No Abstract]    [Full Text] [Related]  

  • 13. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Relapsed Childhood Acute Lymphoblastic Leukemia: Experience from a Single Tertiary Center in Thailand.
    Chotsampancharoen T; Songthawee N; Chavananon S; Sripornsawan P; McNeil EB
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3517-3522. PubMed ID: 36308378
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
    Hou Y; Zi J; Liu S; Ge Q; Ge Z
    Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Association between germline pathogenic variants in cancer-predisposing genes and lymphoma risk.
    Usui Y; Iwasaki Y; Matsuo K; Endo M; Kamatani Y; Hirata M; Sugano K; Yoshida T; Matsuda K; Murakami Y; Maeda Y; Nakagawa H; Momozawa Y
    Cancer Sci; 2022 Nov; 113(11):3972-3979. PubMed ID: 36065483
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Robust Tumoricidal Effects of Combined BET/HDAC Inhibition in Cutaneous T-Cell lymphoma Can Be Reproduced by ΔNp73 Depletion.
    Zhao L; Hsiao T; Stonesifer C; Daniels J; Garcia-Saleem TJ; Choi J; Geskin L; Rook AH; Wood GS
    J Invest Dermatol; 2022 Dec; 142(12):3253-3261.e4. PubMed ID: 35787399
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Multiple-day administration of fosaprepitant combined with tropisetron and olanzapine improves the prevention of nausea and vomiting in patients receiving chemotherapy prior to autologous hematopoietic stem cell transplant: a retrospective study.
    Ye P; Pei R; Wang T; Cao J; Zhang P; Chen D; Liu X; Du X; Li S; Tang S; Hu Y; Jiang L; Lu Y
    Ann Hematol; 2022 Aug; 101(8):1835-1841. PubMed ID: 35668198
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
    Gao Y; Feng X; Song W; Li H; Shi C; Jin M; Li Z; Zhang L; Zhang M
    Hematol Oncol; 2022 Oct; 40(4):678-688. PubMed ID: 35439335
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting the DNA Damage Response to Increase Anthracycline-Based Chemotherapy Cytotoxicity in T-Cell lymphoma.
    Magni M; Paolizzi C; Monfrini C; Vella C; Corradini P; Carniti C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409194
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.